Gene Liau Stoke Therapeutics, Inc. (STOK) insider trading activity

STOK Quotes by TradingView

Gene Liau is EVP Research & Preclinical Dev of Stoke Therapeutics, Inc.. Currently has a direct ownership of 21,351 shares of STOK, which is worth approximately $241,693. The most recent transaction as insider was on Mar 02, 2021, when has been sold 5,195 shares (Common Stock) at a price of $62.99 per share, resulting in proceeds of $327,233. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 21.4K
0% 3M change
0% 12M change
Total Value Held $241,693

Gene Liau Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 02 2021
SELL
Open market or private sale
$327,233 $62.99 p/Share
5,195 Reduced 19.57%
21,351 Common Stock
Mar 02 2021
BUY
Exercise of conversion of derivative security
$3,117 $0.6 p/Share
5,195 Added 16.37%
26,546 Common Stock
Dec 28 2020
SELL
Open market or private sale
$8,751 $58.73 p/Share
149 Reduced 0.69%
21,351 Common Stock
Dec 28 2020
BUY
Exercise of conversion of derivative security
$4,800 $0.6 p/Share
8,000 Added 27.12%
21,500 Common Stock
Oct 19 2020
SELL
Open market or private sale
$1,216,960 $38.03 p/Share
32,000 Reduced 70.33%
13,500 Common Stock
Oct 19 2020
BUY
Exercise of conversion of derivative security
$44,800 $1.4 p/Share
32,000 Added 41.29%
45,500 Common Stock
Oct 16 2020
SELL
Open market or private sale
$234,040 $40.0 p/Share
5,851 Reduced 30.24%
13,500 Common Stock
Oct 16 2020
BUY
Exercise of conversion of derivative security
$3,511 $0.6 p/Share
5,851 Added 23.22%
19,351 Common Stock
Oct 13 2020
SELL
Open market or private sale
$65,960 $40.0 p/Share
1,649 Reduced 10.89%
13,500 Common Stock
Oct 13 2020
BUY
Exercise of conversion of derivative security
$989 $0.6 p/Share
1,649 Added 9.82%
15,149 Common Stock
GL

Gene Liau

EVP Research & Preclinical Dev
Bedford, MA

Track Institutional and Insider Activities on STOK

Follow Stoke Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells STOK shares.

Notify only if

Insider Trading

Get notified when an Stoke Therapeutics, Inc. insider buys or sells STOK shares.

Notify only if

News

Receive news related to Stoke Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on STOK